These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21254099)

  • 1. Anti-ryanodine receptor-positive acetylcholine receptor-negative myasthenia gravis: evidence of impaired excitation-contraction coupling.
    Imai T; Tsuda E; Toyoshima T; Yoshikawa H; Motomura M; Shimohama S
    Muscle Nerve; 2011 Feb; 43(2):294-5. PubMed ID: 21254099
    [No Abstract]   [Full Text] [Related]  

  • 2. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.
    Mygland A; Tysnes OB; Matre R; Volpe P; Aarli JA; Gilhus NE
    Ann Neurol; 1992 Oct; 32(4):589-91. PubMed ID: 1333745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular biology and immunology of acetylcholine receptor in relation to myasthenia gravis].
    Takamori M; Komai K; Iwasa K; Yoshikawa H
    Nihon Rinsho; 1997 Dec; 55(12):3315-21. PubMed ID: 9436457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is excitation-contraction coupling impaired in myasthenia gravis?
    Nakata M; Kuwabara S; Kawaguchi N; Takahashi H; Misawa S; Kanai K; Tamura N; Sawai S; Motomura M; Shiraishi H; Takamori M; Maruta T; Yoshikawa H; Hattori T
    Clin Neurophysiol; 2007 May; 118(5):1144-8. PubMed ID: 17307394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmunity against the ryanodine receptor in myasthenia gravis.
    Skeie GO; Lunde PK; Sejersted OM; Mygland A; Aarli JA; Gilhus NE
    Acta Physiol Scand; 2001 Mar; 171(3):379-84. PubMed ID: 11412151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of anti-ryanodine receptor antibody to impairment of excitation-contraction coupling in myasthenia gravis.
    Imai T; Tsuda E; Hozuki T; Yoshikawa H; Yamauchi R; Saitoh M; Hisahara S; Motomura M; Kawamata J; Shimohama S
    Clin Neurophysiol; 2012 Jun; 123(6):1242-7. PubMed ID: 22136737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acquired autoimmune myasthenia gravis].
    Takamori M
    Ryoikibetsu Shokogun Shirizu; 2001; (36):323-35. PubMed ID: 11596402
    [No Abstract]   [Full Text] [Related]  

  • 8. [Determination and clinical significance of serum anti-ryanodine receptor antibody in patients with myasthenia gravis].
    Cui LY; Li YF; Li YH; Zhang JB
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Apr; 29(2):238-40. PubMed ID: 17536276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ryanodine receptor antibodies in myasthenia gravis: epitope mapping and effect on calcium release in vitro.
    Skeie GO; Mygland A; Treves S; Gilhus NE; Aarli JA; Zorzato F
    Muscle Nerve; 2003 Jan; 27(1):81-9. PubMed ID: 12508299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thymectomy and muscle antibodies in myasthenia gravis].
    Romi F; Gilhus NE; Aarli JA
    Tidsskr Nor Laegeforen; 2004 Mar; 124(5):629-31. PubMed ID: 15004605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striational antibodies in myasthenia gravis: reactivity and possible clinical significance.
    Romi F; Skeie GO; Gilhus NE; Aarli JA
    Arch Neurol; 2005 Mar; 62(3):442-6. PubMed ID: 15767509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-ryanodine receptor antibody and the thymus gland in myasthenia gravis].
    Iwasa K; Asaka T; Takamori M
    Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):655-63. PubMed ID: 9627474
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of complement in myasthenia gravis: serological evidence of complement consumption in vivo.
    Romi F; Kristoffersen EK; Aarli JA; Gilhus NE
    J Neuroimmunol; 2005 Jan; 158(1-2):191-4. PubMed ID: 15589053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early effect of tacrolimus in improving excitation-contraction coupling in myasthenia gravis.
    Imai T; Tsuda E; Hozuki T; Yamauchi R; Saitoh M; Hisahara S; Yoshikawa H; Motomura M; Kawamata J; Shimohama S
    Clin Neurophysiol; 2012 Sep; 123(9):1886-90. PubMed ID: 22386321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-ryanodine receptor antibodies and FK506 in myasthenia gravis.
    Takamori M; Motomura M; Kawaguchi N; Nemoto Y; Hattori T; Yoshikawa H; Otsuka K
    Neurology; 2004 May; 62(10):1894-6. PubMed ID: 15159506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myasthenia gravis].
    Kawaguchi N; Hattori T
    Nihon Rinsho; 2005 May; 63 Suppl 5():416-21. PubMed ID: 15954385
    [No Abstract]   [Full Text] [Related]  

  • 17. Autoantibodies against TRPC3 and ryanodine receptor in myasthenia gravis.
    Takamori M
    J Neuroimmunol; 2008 Aug; 200(1-2):142-4. PubMed ID: 18602703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acetylcholine receptor antibody titer, sensitivity to curare electromyogram and disease severity in myasthenia gravis].
    Chen SM
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Jun; 24(3):169-73, 189. PubMed ID: 1889330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-AChR-negative myasthenia gravis: clinical and immunological features.
    Evoli A; Bartoccioni E; Batocchi AP; Scuderi F; Tonali P
    Clin Invest Med; 1989 Apr; 12(2):104-9. PubMed ID: 2706833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.